Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Pancreas. 2017 Mar;46(3):405–409. doi: 10.1097/MPA.0000000000000768

Table 3.

Prediction model for abnormal ePFT and weighted risk score

Parameter All
Patients
(n=176),
n (%)*
Abnormal
ePFT (n=69),
n (%)
Model
Coefficient
p-value Risk
Score
Behavior (current or previous smoking/alcohol use)
None 76 (43) 18 (24) reference N/A 0
Smoking OR alcohol status 65 (37) 29 (45) 0.39 0.35 2
Smoking AND alcohol status 35 (20) 22 (63) 0.76 0.15 4
Number of parenchymal abnormalities present (cysts, strands, hyperechoic foci, and
lobularity)
0 29 (16) 4 (14) reference N/A 0
1 or 2 112 (64) 43 (38) 1.05 0.10 6
3 or 4 35 (20) 22 (63) 1.46 0.05 8
Number of ductal abnormalities present (irregular MPD, dilated MPD, and dilated side
branches)
0 124 (70) 34 (27) reference 0
1 23 (13) 9 (39) 0.19 0.71 1
2 or 3 29 (16) 26 (90) 2.14 0.002 11
Calcifications
No 154 (88) 49 (35) reference N/A 0
Yes 22 (13) 20 (91) 1.79 0.03 9
*

Column % does not necessarily add to 100 due to rounding.

Row %

Risk score was calculated by dividing each variable coefficient by the smallest coefficient in the model and rounding the ratio to the integer.